Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification

Journal of Cataract and Refractive Surgery

Volumn 30, Issue 4, 2004, Pages 761-768

  Wadood, Azfar C ^a,c   Armbrecht, Ana M ^a,b   Aspinall, Peter A ^a,b   Dhillon, Baljean ^a,b  

^a NHS LOTHIAN   (United Kingdom)

^b HERIOT WATT UNIVERSITY   (United Kingdom)

^c PRINCESS ALEXANDRA EYE PAVILION   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIGLAUCOMA AGENT; ARTIFICIAL TEAR; CEFUROXIME; CHLORAMPHENICOL; CODEINE; DEXAMETHASONE; EYE DROPS; MYDRIATIC AGENT; PARACETAMOL; PLACEBO; SODIUM CHLORIDE; STEROID;

ADULT; AGED; ANTERIOR EYE CHAMBER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; EYE INFLAMMATION; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; LASER FLARE CELL METER; LENS IMPLANTATION; MALE; OUTCOMES RESEARCH; PHACOEMULSIFICATION; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; SLIT LAMP; SPECULAR MICROSCOPY;

AGED; ANTERIOR EYE SEGMENT; DEXAMETHASONE; DRUG DELIVERY SYSTEMS; FEMALE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; LENS IMPLANTATION, INTRAOCULAR; MALE; MICROSPHERES; OPHTHALMIC SOLUTIONS; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATIONS; SAFETY; SINGLE-BLIND METHOD; TREATMENT OUTCOME; UVEITIS, ANTERIOR;

EID: 16544369509     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2003.08.028     Document Type: Article

References (17)

1. Leopold I.H. Nonsteroidal and steroidal anti-inflammatory agents. Sears M.L., Tarkkanen A. Surgical Pharmacology of the Eye. 1985;83-133 Raven Press, New York, NY.
2. Tennant J.L. Cystoid maculopathy; prostaglandins in ophthalmology. Emery J.M. Current Concepts in Cataract Surgery; Selected Proceedings of the Fifth Biennial Cataract Surgical Congress. 1978;360-362 Mosby, St Louis, MO.
3. Apple D.J., Solomon K.D., Tetz M.R.et al. Posterior capsule opacification. Surv Ophthalmol. 37:1992;73-116.
4. Sanders D.R., Kraff M. Steroidal and nonsteroidal anti-inflammatory agents; effect on postsurgical inflammation and blood-aqueous humor barrier breakdown. Arch Ophthalmol. 102:1984;1453-1456.
5. Ferguson V.M., Spalton D.J. Recovery of the blood-aqueous barrier after cataract surgery. Br J Ophthalmol. 75:1991;106-110.
6. Kass M.A., Meltzer D.W., Gordon M.et al. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 101:1986;515-523.
7. Winfield A.J., Jessiman D., Williams A., Esakowitz L. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol. 74:1990;477-480.
8. Ichigashira N., Yamaga N. Intraocular fate of dexamethasone disodium phosphate topically applied to the eyes of rabbits. Steroids. 32:1978;615-628.
9. Assil K.K., Massry G., Lehmann R.et al. Control of ocular inflammation after cataract extraction with rimexolone 1% ophthalmic suspension. J Cataract Refract Surg. 23:1997;750-757.
10. Bron A., Denis P., Hoang-Xuan T.C.et al. The effects of rimexolone 1% in postoperative inflammation after cataract extraction. A double-masked placebo-controlled study. Eur J Ophthalmol. 8:1998;16-21.
11. Chang D.F., Garcia I.H., Hunkeler J.D., Minas T. Phase II results of an intraocular steroid delivery system for cataract surgery. Ophthalmology. 106:1999;1172-1177.
12. Tan D.T.H., Chee S.-P., Lim L., Lim A.S. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation. Ophthalmology. 106:1999;223-231.
13. Tan D.T.H., Chee S.-P., Lim L.et al. Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery; anterior versus posterior placement of two Surodex in the eye. Ophthalmology. 108:2001;2172-2181.
14. Bodor N. Designing safer ophthalmic drugs by soft drug approaches. J Ocular Pharmacol. 10:1994;3-15.
15. Krupin T., Waltman S.R., Becker B. Ocular penetration in rabbits of topically applied dexamethasone. Arch Ophthalmol. 92:1974;312-314.
16. Sawa M., Tsurimaki Y., Tsuru T., Shimizu H. New quantitative method to determine protein concentration and cell number in aqueous in vivo. Jpn J Ophthalmol. 32:1988;132-142.
17. El-Maghraby A., Marzouki A., Matheen T.M.et al. Reproducibility and validity of laser flare/cell meter measurements of intraocular inflammation. J Cataract Refract Surg. 19:1993;52-55.